[New pathophysiological concepts in pulmonary hypertension in COPD]

Area of Science:

• Pulmonary Medicine
• Cardiovascular Research
• Respiratory Diseases

Background:

• Pulmonary hypertension (PH) frequently complicates chronic obstructive pulmonary disease (COPD), significantly impacting prognosis.
• In advanced COPD, PH is driven by pulmonary vascular remodeling and hypoxia-induced vasoconstriction.
• Emerging evidence suggests pulmonary artery structural changes occur even in early COPD stages, prior to significant hypoxemia.

Purpose of the Study:

• To investigate the mechanisms of structural and functional alterations in pulmonary vessels in COPD.
• To explore the role of cigarette smoke components and inflammation in COPD-associated pulmonary vascular remodeling.
• To elucidate the contribution of endothelial dysfunction to the pathogenesis of PH in COPD.

Main Methods:

• Analysis of pathological changes in pulmonary arteries in COPD patients.
• Investigation of the effects of cigarette smoke extract on pulmonary artery endothelial cells.
• Assessment of inflammatory markers in lung tissue and serum of COPD patients.

Main Results:

• Structural anomalies in pulmonary arteries are present early in COPD, independent of severe hypoxemia.
• Cigarette smoke exposure directly and indirectly (via inflammation) damages pulmonary artery endothelium.
• Endothelial dysfunction is a key factor in the development of pulmonary vascular remodeling in COPD, similar to primary PH.

Conclusions:

• Pulmonary vascular remodeling in COPD begins early and is influenced by smoking and inflammation.
• Endothelial dysfunction is a critical, shared pathway in both COPD-associated PH and primary PH.
• Targeting endothelial dysfunction may offer therapeutic strategies for PH in COPD patients.